UK women health diagnostics market is growing at a CAGR of approximately 9.3% during the forecast period. The UK is one of the major countries in the European region, there are many factors such as rising cancer in women, growth of healthcare infrastructure and so on which augment the UK women health diagnostic market. According to the index of economic freedom, the population of the UK in the year 2018 is around 65.6 million. The UK has few price controls but does regulate rates for most utilities and partly controls the price of prescription drugs. This increases the market player’s business activities in this region. Overall net national income is also augmented in this region, this increases the women spending on health, pregnancy and other women related diseases and disorders, which enhances the UK women health diagnostic market during the forecast period.
A full report of UK Women Health Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/uk-women-health-diagnostics-market
Heart diseases are the most common cause of death, it accounts for 1.8 times as many mortalities as the second leading cause of death: dementia and Alzheimer’s disease. For females, dementia and Alzheimer’s are the common cause of mortalities, followed by heart disease. Cancers accounted for 30% of mortality in males and around 24.8% of mortality in females. When considered separately, 4 of the 10 leading causes of fatality in males and females were cancers. Breast cancer was around the top fatalities in women. Thus, such a high prevalence of diseases is likely to increase the demand for diagnosis and treatment options, which in turn increases the UK women health diagnostics market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-women-health-diagnostics-market
There prominent players operating in the UK women health diagnostics market include Abbott Laboratories, Hologic Inc., Becton, Dickson and Co., Biomerieux SA, among others which are strengthening the position of this region by offering various women health diagnostic products in Canada. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
UK Women Health Diagnostics Market- Segmentation
- Breast Cancer Testing
- Cervical Cancer Testing
- Pregnancy & Fertility Testing
- Ovarian Cancer Testing
- Infectious Disease Testing
- Ultrasound Tests
- Sexually Transmitted Disease Testing
- Others (Osteoporosis Testing and Prenatal Genetic Testing)
- Diagnostic and Imaging Centers
- Hospitals and Clinics
- Home Care
Visit for Global Women Health Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size
- Abbott Laboratories, Inc.
- Becton, Dickson and Co.
- Biomerieux SA
- EKF Diagnostics Holdings PLC
- F. Hoffmann-La Roche Ltd.
- GenMark Diagnostics, Inc.
- Hologic Inc.
- Koninklijke Philips N.V.
- Nova Biomedical Pte. Ltd.
- PerkinElmer Inc.
- QIAGEN N.V.
- Siemens AG
- Thermo Fisher Scientific Inc.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404